Retatrutide

Buy Retatrutide in Canada from Legacy Laboratories. Retatrutide is a next-generation “triple G” agonist that simultaneously targets the GIP, GLP-1, and glucagon receptors.

What Is Retatrutide?

Retatrutide adds glucagon-receptor activity to the dual mechanism of Tirzepatide, which may further increase energy expenditure.

How Retatrutide Works

The added glucagon agonism is associated with increased metabolic rate, while GIP and GLP-1 activity drive appetite suppression and improved glucose handling.

Research & Potential Benefits

• Some of the largest weight reductions reported in phase-2 obesity trials
• Improved glycaemic control
• Potential benefits for metabolic-associated fatty liver

Review the published phase-2 results indexed on PubMed.

Stacking Retatrutide

Retatrutide is researched alongside Cagrilintide and other GLP-1 / GIP analogues such as Semaglutide.

Important Information

The information above is provided for educational and research purposes only and has not been evaluated by Health Canada or the U.S. Food & Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease. Semaglutide and Tirzepatide are prescription medications in many jurisdictions; nothing here is medical advice. Always consult a licensed healthcare professional before beginning any new compound.